Congenital rubella syndrome (CRS) can occur in a developing fetus of a pregnant woman who has contracted rubella, usually in the first trimester. If infection occurs 0–28 days before conception, the infant has a 43% chance of being affected. If the infection occurs 0–12 weeks after conception, the chance increases to 51%. If the infection occurs 13–26 weeks after conception, the chance is 23% of the infant being affected by the disease. Infants are not generally affected if rubella is contracted during the third trimester, or 26–40 weeks after conception. Problems rarely occur when rubella is contracted by the mother after 20 weeks of gestation and continues to disseminate the virus after birth.
The molecular basis for the causation of congenital rubella syndrome are not yet completely clear, but in vitro studies with cell lines showed that rubella virus has an apoptotic effect on certain cell types. There is evidence for a p53-dependent mechanism.
^Megyeri K, Berencsi K, Halazonetis TD et al. (June 1999). "Involvement of a p53-dependent pathway in rubella virus-induced apoptosis". Virology259 (1): 74–84. doi:10.1006/viro.1999.9757. PMID10364491.CS1 maint: Explicit use of et al. (link)